Press Enter to search · ESC to close

Macro US Stocks

CXO Firms Report Strong Order Backlogs, Industry Outlook Seen Extending

Several listed CXO companies said at their third-quarter earnings briefings that order backlogs remain ample and full-year results are expected to grow, as demand for pharmaceutical R&D services recovers alongside faster out-licensing deals for innovative drugs. With project deliveries set to expand further in the fourth quarter, the sector’s upcycle is expected to continue.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback